Beruflich Dokumente
Kultur Dokumente
Etopophos shortage
The TGA has provided an update
TGA plots new CM regime Digital pharmacies
Pharmacies have an excellent
on shortages of Etopophos powder The Therapeutic Goods has been assessed by the TGA for opportunity to take part in the
for injection vials and Vepesid Administration is seeking feedback efficacy, where their product has connected health trend as digital
etoposide capsules from Bristol- on key reforms to the regulation undergone pre-market assessment health improves health monitoring,
Myers Squibb Australia, used for of complementary medicines, with by the government agency. lowers costs to organisations and
the treatment of conditions such as the aim of increasing transparency The paper focuses on the provides consumers new ways
lung cancer and Hodgkins disease. for consumers, providing implementation of four of the of monitoring chronic disease,
Etopophos etoposide phosphate additional flexibility for industry nineteen recommendations from according to Propell Health, the
powder for injection vials are and supporting innovation - while the Review, with these chosen Australasian distributor of the
unavailable until 01 Apr 2017, maintaining the safety and quality because they would have the most iHealth range of personal health
while 50mg capsule blister packs of of therapeutic goods in Australia. significant impact on reshaping the apps and devices.
Vepeside etoposide are out of stock The proposals are a response CM regulatory framework. Propell Healths Craig Simmonds
from 28 Feb until 01 Apr. to the governments Review of The reforms also aim to recently attended the massive
However the previous shortage of Medicines and Medical Devices encourage innovation in the sector, Consumer Electronics Show in Las
100mg Vepeside etoposide capsule Regulation, and involve the including a two year exclusivity Vegas, where he said the focus was
blister pack has been resolved. development of a new three-tiered period for newly approved clearly on patient-oriented care.
risk-based framework. ingredients in listed medicines. It is clear digital or connected
In particular, the plan would The new assessment pathway for health has become mainstream.
Telstra Health chief introduce a new assessment CMs also aims to encourage further Wearables are nowhere as
Former NSW Health director- pathway for CMs, sitting between research and development. prevalent as they once were.
general Mary Foley has been the existing listed medicine (low If sponsors have supporting data, Chronic disease monitoring
named as the new managing risk) and registered medicine implementation of a new approval devices linked to apps is what the
director of Telstra Health. (high risk) pathways. pathway may allow sponsors to global market is backing.
She replaces founding MD Shane The consultation also suggest the have exclusive use of intermediate Blood pressure, blood glucose,
Solomon who retires this month development of a list of permitted level indications that fall outside pulse oximetry and ECG monitoring
after conducting a spending spree indications which must be used the permissible indications list, the are now all connected to apps, he
on health technology acquisitions by the lowest risk complementary consultation paper suggests. added, identifying the big global
including a 50% stake in pharmacy medicines, while sponsors will Feedback is sought by COB on 28 brands leading the charge as
software provider Fred IT. be able to claim their medicine Mar 2017 - see tga.gov.au. iHealth, Withings and Philips.
TM
FLU
VACCINATION
SERVICES
WEVE GOT YOU COVERED
Kick off your flu season services using our nurses to deliver
dedicated clinic days with a high vaccination rate.
Maintain this service throughout the season using your accredited
pharmacist, whilst still getting access to APO-Wellness benefits.
Apotex Pty Ltd Macquarie Park NSW 2113 ABN 52 096 916 148. APOTEX and APO-Wellness are trademarks used under license.
Copyright 2017. All rights reserved. MKT-AU-0649/6 January 2017. www.apotex.com.au
Pharmacy Daily Wednesday 15th February 2017 t 1300 799 220 w www.pharmacydaily.com.au page 1
KEEP UP TO DATE WITH
THE LATEST INFORMATION
O
dreambaby.com.au contraceptives to women who
meet the specified criteria with
G
To win, be the first person from WA
to send the correct answer to the the same levels of safety as other Australian Pharmacy Professional !
TO
question below to healthcare professionals, Medsafe Conference & Trade Exhibition W
O
KS
comp@pharmacydaily.com.au said in a statement yesterday.
The reclassification will come N
R
What is the only temperature
EE E
drinks should be when being into effect by the end of Feb, while
availability of oral contraceptives
I ST
W
held in the Dreambaby
from a pharmacy will only start
Strollerbuddy drink holder? G
Congratulations to yesterdays winner,
Noelene Morris from Marlin Coast Amcal.
once pharmacists have been
deemed appropriately trained. 3 R E
THE PHARMACY
OF THE FUTURE
Preview the transformation
solution at our APP stand
+ Valuable coaching
+ Comprehensive tools and resources
+ Proven results
Wondering how other
pharmacies aretransforming? VISIT STAND 911
Pharmacy Daily Wednesday 15th February 2017 t 1300 799 220 w www.pharmacydaily.com.au page 2
Do you have the Pharmacy
Daily app?
Dispensary
Health, Beauty
Welcome to our weekly promoted
feature with all the latest health,
Corner beauty and new products for pharmacy.
Pharmacy Daily is Australias favourite pharmacy industry publication. Publisher/Editor in chief: Bruce Piper Editorial: info@pharmacydaily.com.au
Sign up free at www.pharmacydaily.com.au. Managing Editor: Jon Murrie
Postal address: PO Box 1010, Epping, NSW 1710 Australia Reporter: Mal Smith
Street address: Level 2, Suite 1 64 Talavera Rd, Macquarie Park NSW 2113 Australia Contributors: Nathalie Craig, Jasmine ODonoghue, Bonnie Tai
Advertising and Marketing: Sean Harrigan and Melanie Tchakmadjian advertising@pharmacydaily.com.au
P: 1300 799 220 (+61 2 8007 6760) F: 1300 799 221 (+61 2 8007 6769)
Business Manager: Jenny Piper accounts@pharmacydaily.com.au
Part of the Business Publishing Group.
business events news
Pharmacy Daily is a publication of Pharmacy Daily Pty Ltd ABN 97 124 094 604. All content fully protected by copyright. Please obtain written permission to reproduce any material. While every care has been taken in the preparation of
the newsletter no liability can be accepted for errors or omissions. Information is published in good faith to stimulate independent investigation of the matters canvassed. Responsibility for editorial comment is taken by Bruce Piper.
Pharmacy Daily Wednesday 15th February 2017 t 1300 799 220 w www.pharmacydaily.com.au page 3